Canada markets close in 5 hours 31 minutes

Ascletis Pharma Inc. (2VJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1480+0.0150 (+11.28%)
As of 09:59AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
56,596
56,596
54,090
76,876
35,001
Cost of Revenue
30,606
30,606
78,782
37,703
58,498
Gross Profit
25,990
25,990
-24,692
39,173
-23,497
Operating Expenses
Research Development
216,781
216,781
267,102
213,320
109,099
Selling General and Administrative
62,963
62,963
21,187
25,315
32,576
Total Operating Expenses
326,198
326,198
314,937
223,256
129,439
Operating Income or Loss
-300,208
-300,208
-339,629
-184,083
-152,936
Interest Expense
144
144
157
125
135
Income Before Tax
-144,715
-144,715
-314,843
-199,017
-209,241
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-144,715
-144,715
-314,843
-199,017
-209,241
Net Income
-144,715
-144,715
-314,843
-199,017
-209,241
Net Income available to common shareholders
-144,715
-144,715
-314,843
-199,017
-209,241
Basic EPS
-0.22
-0.13
-0.29
-0.18
-0.20
Diluted EPS
-0.22
-0.13
-0.29
-0.18
-0.20
Basic Average Shares
1,087,030
1,074,103
1,087,030
1,097,608
1,040,056
Diluted Average Shares
1,087,030
1,074,103
1,087,030
1,097,608
1,040,056